Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1983 Dec;18(6):1296-300.
doi: 10.1128/jcm.18.6.1296-1300.1983.

Comparison of five methods of cytomegalovirus antibody screening of blood donors

Comparative Study

Comparison of five methods of cytomegalovirus antibody screening of blood donors

P H Phipps et al. J Clin Microbiol. 1983 Dec.

Abstract

A group of 120 sera from blood donors was screened by complement fixation and commercially available immunofluorescence, solid-phase fluorescence immunoassay, enzyme-linked immunosorbent assay, and indirect hemagglutination tests. Twenty-four of the sera were positive by three or more of the five tests and judged to be true positives; 89 were negative by three or more of the tests and considered to be true negatives. The tests were ranked for accuracy, sensitivity, specificity, false-positive rate, and false-negative rate. The indirect hemagglutination test scored best, followed by enzyme-linked immunosorbent assay, solid-phase fluorescence immunoassay, complement fixation, and immunofluorescence, in that order. When the tests were ranked on the basis of technical demands, turnaround time, requirement for special equipment, and subjectivity in reading, the indirect hemagglutination test again scored best, followed by solid-phase fluorescence immunoassay, enzyme-linked immunosorbent assay, immunofluorescence, and complement fixation in that order. Our findings suggest that the indirect hemagglutination test is the most reliable and effective commercially available test for the identification of those donors who are very unlikely to transmit cytomegalovirus to recipients.

PubMed Disclaimer

References

    1. Proc Soc Exp Biol Med. 1969 Dec;132(3):957-62 - PubMed
    1. Transfusion. 1977 Jul-Aug;17(4):391-5 - PubMed
    1. J Infect Dis. 1977 Nov;136(5):667-78 - PubMed
    1. J Pediatr. 1981 Feb;98(2):281-7 - PubMed
    1. Ann Intern Med. 1980 Nov;93(5):671-5 - PubMed

Publication types

MeSH terms

Substances